BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 20947824)

  • 1. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis.
    Skoura A; Michaud J; Im DS; Thangada S; Xiong Y; Smith JD; Hla T
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):81-5. PubMed ID: 20947824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.
    Wang F; Okamoto Y; Inoki I; Yoshioka K; Du W; Qi X; Takuwa N; Gonda K; Yamamoto Y; Ohkawa R; Nishiuchi T; Sugimoto N; Yatomi Y; Mitsumori K; Asano M; Kinoshita M; Takuwa Y
    J Clin Invest; 2010 Nov; 120(11):3979-95. PubMed ID: 20978351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.
    Keul P; Lucke S; von Wnuck Lipinski K; Bode C; Gräler M; Heusch G; Levkau B
    Circ Res; 2011 Feb; 108(3):314-23. PubMed ID: 21164103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway.
    Yang J; Yang L; Tian L; Ji X; Yang L; Li L
    Cell Physiol Biochem; 2018; 49(5):1677-1693. PubMed ID: 30231248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
    Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
    J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
    Shen J; Chandrasekharan UM; Ashraf MZ; Long E; Morton RE; Liu Y; Smith JD; DiCorleto PE
    Circ Res; 2010 Mar; 106(5):902-10. PubMed ID: 20093631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.